Halifax Research & Innovation Focus
Pharmaceuticals & Vaccines – Innovating from Lab to Market
Summary
Halifax is advancing pharmaceuticals, vaccines and biotechnology from early research through clinical testing and commercialization. The city’s collaborative ecosystem connects researchers, hospitals, health-system partners, and growing biopharma companies working in vaccine development, immunotherapy, infectious disease, and drug discovery.
Nova Scotia Health supports approximately 400 clinical trials at any given time, while the Atlantic Clinical Trials Network extends access across a regional population of roughly 2.5 million people. The Canadian Center for Vaccinology adds more than 20 investigators working across vaccine discovery, clinical evaluation, implementation, policy and ethics, strengthening Halifax’s role as a launchpad for health innovations with national and global potential.
Research Facilities
Local Expertise
Dr. Joanne Langley
Vaccinology and infectious disease leader. Conducts clinical trials and evidence-based immunization research through Halifax’s Canadian Center for Vaccinology, helping shape vaccine development and public health policy internationally.
Notable Meetings
CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research Meeting 2026
International Society for Laboratory Hematology Annual Meeting 2025 (500 Attendees)
Diabetes Canada & Canadian Society of Endocrinology and Metabolism Professional Conference 2024 (1,500 Attendees)
International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) 2023
International Conference on Pharmacoepidemiology and Therapeutic Risk Management 2023 (1,200 Attendees)
Canadian Society for Immunology Annual Conference 2022
Canadian Association of Pharmacy in Oncology (CAPhO) Conference 2019
View All Events Show Fewer Events
The Canadian Society of Allergy and Clinical Immunology (CSACI) Annual Scientific Meeting 2018
Canadian Public Health Association Annual Conference 2017 (1,000 Attendees)